Literature DB >> 22837319

Utilizing rapid multiple-locus variable-number tandem-repeat analysis typing to aid control of hospital-acquired Clostridium difficile Infection: a multicenter study.

Katherine Hardy1, Susan Manzoor, Claire Marriott, Helen Parsons, Claire Waddington, Savita Gossain, Ala Szczepura, Nigel Stallard, Peter M Hawkey.   

Abstract

The early identification of outbreaks is crucial for the control of Clostridium difficile infection. This study aimed to determine if the number of hospital-acquired C. difficile infections could be reduced by rapidly typing C. difficile strains using multiple-locus variable-number tandem-repeat analysis (MLVA) compared to typing using PCR ribotyping. A total of 16 hospitals were recruited to the study, and all periods of increased incidence (PIIs) of C. difficile infection were identified. The hospitals were randomized into two study arms, the test and the control, with all isolates typed in the test using MLVA and in the control using PCR ribotyping. Following a PII, each hospital received a structured questionnaire regarding control measures implemented or stopped prior to or following the typing results. During the study period, there were a total of 1,682 hospital-apportioned C. difficile toxin-positive cases, with 868 in the control and 814 in the test, with modeling demonstrating no differences between the two arms. A total of 245 PIIs occurred, involving 785 patients. There was a significant difference in the mean turnaround time between the ribotyping and MLVA typing (13.6 and 5.3 days, respectively [P < 0.001]). The discriminatory ability of MLVA was greater than ribotyping, with 85 outbreaks being confirmed by ribotyping and 62 by MLVA. In the test arm, 40.6% of respondents strongly agreed that the typing result had aided their management of clusters, as opposed to 9.9% in the control. The study demonstrated the utility of rapidly typing C. difficile strains, demonstrating that it aided the management of clusters, enabling effective targeting of infection control resources.

Entities:  

Mesh:

Year:  2012        PMID: 22837319      PMCID: PMC3457454          DOI: 10.1128/JCM.00784-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Mycobacterial interspersed repetitive unit typing of Mycobacterium tuberculosis compared to IS6110-based restriction fragment length polymorphism analysis for investigation of apparently clustered cases of tuberculosis.

Authors:  Peter M Hawkey; E Grace Smith; Jason T Evans; Philip Monk; Gerry Bryan; Huda H Mohamed; Madhu Bardhan; R Nicholas Pugh
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

2.  PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes.

Authors:  S L Stubbs; J S Brazier; G L O'Neill; B I Duerden
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

3.  Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals.

Authors:  Jane W Marsh; Mary M O'Leary; Kathleen A Shutt; A William Pasculle; Stuart Johnson; Dale N Gerding; Carlene A Muto; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 4.  Emergence of Clostridium difficile-associated disease in North America and Europe.

Authors:  E J Kuijper; B Coignard; P Tüll
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

5.  Reducing Clostridium difficile through early identification of clusters and the use of a standardised set of interventions.

Authors:  K J Hardy; S Gossain; D Thomlinson; D G Pillay; P M Hawkey
Journal:  J Hosp Infect       Date:  2010-03-12       Impact factor: 3.926

6.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

7.  Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis.

Authors:  Renate J van den Berg; Inge Schaap; Kate E Templeton; Corné H W Klaassen; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

8.  Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods.

Authors:  Kerrie Eastwood; Patrick Else; André Charlett; Mark Wilcox
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

9.  Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing.

Authors:  George Killgore; Angela Thompson; Stuart Johnson; Jon Brazier; Ed Kuijper; Jacques Pepin; Eric H Frost; Paul Savelkoul; Brad Nicholson; Renate J van den Berg; Haru Kato; Susan P Sambol; Walter Zukowski; Christopher Woods; Brandi Limbago; Dale N Gerding; L Clifford McDonald
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

10.  Coexistence of multiple multilocus variable-number tandem-repeat analysis subtypes of Clostridium difficile PCR ribotype 027 strains within fecal specimens.

Authors:  Hannah E Tanner; Katherine J Hardy; Peter M Hawkey
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

View more
  7 in total

1.  CAGS Clinical Practice Committee report: the science of Clostridium difficile and surgery.

Authors:  Shahzeer Karmali; Michael Laffin; Christopher de Gara
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

2.  Development and evaluation of a novel, semiautomated Clostridium difficile typing platform.

Authors:  Lars F Westblade; Robin R Chamberland; Duncan MacCannell; Rachel Collins; Erik R Dubberke; W Michael Dunne; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

3.  Overview report on the application of double digest selective label (DDSL) bacteria genotyping technique for identification of strains and certification of commercially used bacteria.

Authors:  V Terletskiy
Journal:  3 Biotech       Date:  2020-01-24       Impact factor: 2.406

Review 4.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 5.  Challenges for standardization of Clostridium difficile typing methods.

Authors:  Charlotte A Huber; Niki F Foster; Thomas V Riley; David L Paterson
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

6.  A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection.

Authors:  Martina Neuendorf; Raquel Guadarrama-Gonzalez; Birgit Lamik; Colin R MacKenzie
Journal:  BMC Microbiol       Date:  2016-02-12       Impact factor: 3.605

7.  How do hospital professionals involved in a randomised controlled trial perceive the value of genotyping vs. PCR-ribotyping for control of hospital acquired C. difficile infections?

Authors:  Ala Szczepura; Susan Manzoor; Katherine Hardy; Nigel Stallard; Helen Parsons; Savita Gossain; Peter M Hawkey
Journal:  BMC Infect Dis       Date:  2014-03-21       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.